Catalyst Wire Dossier Catalyst Wire Dossier

Trans-resveratrol (BIA 6-512)

trans-resveratrol · Bial - Portela C S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Trans-resveratrol (BIA 6-512), covering 2017-03-29 to 2017-03-29. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Food on BIA 6-512 (Trans-resveratrol) [Phase 1]

See pricing